apixaban,
BMS 562247,
BMS-562247,
BMS562247,
Apixaban,
503612-47-3,
Eliquis,
BMS-562247-01,
BMS 562247-01,
BMS-562247,
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide,
apixabanum,
UNII-3Z9Y7UWC1J,
1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide,
3Z9Y7UWC1J,
CHEMBL231779,
CHEBI:72296,
Apixaban(BMS-562247-01),
BMS562247-01,
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-,
J-200194,
1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide,
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide,
Eliquis (TN),
Apixaban (JAN/USAN/INN),
Apixaban [USAN:INN:JAN],
Apixabin,
HSDB 8223,
Apixaban - Adooq Bioscience,
MLS006010026,
SCHEMBL118023,
GTPL6390,
PYR431,
Apixaban BMS-562247-01,
Apixaban,BMS-562247-01,
Apixaban;503612-47-3,
BDBM19023,
DTXSID80436500,
EX-A048,
2p16,
QNZCBYKSOIHPEH-UHFFFAOYSA-N,
BCPP000396,
HMS3655O07,
AOB87769,
BCP02451,
Apixaban (BMS 562247-01),
Apixaban/BMS562247-01/Apixaban,
ABP000333,
AN-429,
CA0186,
MFCD11977295,
s1593,
ZINC11677837,
AKOS005146204,
BCP9000310,
CCG-229675,
CS-0401,
DB06605,
ME-0152,
PB10976,
QC-8191,
RP18047,
KS-0000075V,
NCGC00346555-01,
NCGC00346555-08,
AC-26301,
AJ-59962,
AK161862,
BC654125,
GG2,
HY-50667,
SC-49755,
SMR004676529,
AB0007933,
AB1008435,
AX8161411,
FT-0686944,
ST24045978,
SW220177-1,
X1060,
D03213,
Q-4456,
AB01565766_02,
612A473,
I14-11577,
1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo(3,4c)pyridine-3-carboxamide,
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo piperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide,
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide,
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide,
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide?BMS-562247; BMS-562247-01,
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-car,
1H-Pyrazolo(3,4-c)pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-,
Apixaban [USAN],
D0I5HF,
cc-395,
BMS-562247-01, Apixaban,
C25H25N5O4,
C25-H25-N5-O4,
ACN-031561,
BMS 562247,
CS-O-00932,
CID10182969,
A4341,
A10082,
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide,
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd,